Vastagbélrák: vizsgálatok itt: Kína
616 trials · From ClinicalTrials.gov, checked 2026. november 17.. Ask the study team whether a trial fits you.
- 3. fázisTaking peoplePreoperative Short-course Radiation Followed by Envafolimab Plus CAPEOX for MSS Locally Advanced Rectal Adenocarcinoma
- Where
- Hangzhou
- Életkor
- 18 év and over
- People
- 108
- Run by
- Sir Run Run Shaw Hospital
See details and how to joinNCT05752136 - 2. fázisTaking peopleFMT+ QL1706+Bevacizumab+ XELOX as First-line Treatment for Advanced MSS-type Colorectal Cancer With Liver Metastasis
- Where
- Changzhou
- Életkor
- 18 év to 75 év
- People
- 30
- Run by
- Hua Jiang
See details and how to joinNCT06801665 - 2. fázisTaking peopleBevacizumab, Sintilimab, Cetuximab and Irinotecan in Refractory RAS Wild-type Metastatic Colorectal Cancer: BOND-4 Trial
- Where
- Guangzhou
- Életkor
- 18 év to 75 év
- People
- 160
- Run by
- Guangdong Provincial People's Hospital
See details and how to joinNCT07722754 - 2. fázisTaking peopleStudy of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
- Where
- Changsha, Chongqing, Guangzhou, Hangzhou, Hefei, Shanghai, Shenyang, Wuhan, Xi'an, Zhengzhou
- Életkor
- 18 év to 130 év
- People
- 454 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT05489211 · EU 2023-509436-26-00 - 1/2. fázisTaking peopleA Clinical Trial Evaluating TQB2930 Injection and Chemotherapy With or Without Bevacizumab in Patients With HER2-Abnormally Expressed Unresectable Locally Advanced or Metastatic Colorectal Cancer.
- Where
- Beijing, Changchun, Changsha, Chongqing, Foshan, Guangzhou, Harbin, Jingzhou, Lanzhou, Lishui, Nanchang, Nanjing, Nanning, Qiqihar, Shanghai, Shenyang, Tianjin, Ürümqi, Wuhan, Xi'an, Xi’an, Zhengzhou, Zunyi
- Életkor
- 18 év to 75 év
- People
- 71
- Run by
- Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
See details and how to joinNCT07653685 - 2. fázisTaking peopleEfficacy and Safety of Retlirafusp Alfa Plus Bevacizumab and Chemotherapy With or Without Short-Course Radiotherapy in Patients With CRCLM
- Where
- Wuhan
- Életkor
- 18 év to 75 év
- People
- 60
- Run by
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
See details and how to joinNCT07728019 - 2. fázisTaking peopleLocal Methylene Blue Injection for Prevention of Anastomotic Leakage and Permanent Stoma After Low Anterior Resection for Rectal Cancer
- Where
- Beijing
- Életkor
- 18 év and over
- People
- 26
- Run by
- Peking University Cancer Hospital & Institute
See details and how to joinNCT07833319 - 3. fázisTaking peopleNeoadjuvant Chemoradiotherapy Followed by Chemotherapy With or Without Tislelizumab for Resectable Ultra-low Rectal Cancer: The RELIEVE-02 Study
- Where
- Shanghai
- Életkor
- 18 év to 75 év
- People
- 196
- Run by
- Fudan University
See details and how to joinNCT07132463 - No phaseTaking peopleMultimodal Survival Prediction Model for Colorectal Liver Metastases Post-Operation
- Where
- Hefei
- Életkor
- 18 év to 80 év
- People
- 205
- Run by
- Anhui Provincial Hospital
See details and how to joinNCT07830576 - 1/2. fázisTaking peopleStudy of BPI-572270 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
- Where
- Hangzhou
- Életkor
- 18 év and over
- People
- 120 worldwide
- Run by
- Betta Pharmaceuticals Co., Ltd.
See details and how to joinNCT07435038 - No phaseTaking peoplePrecision Navigation to Improve Community Cancer Screening Participation
- Where
- Huaihua, Shaoyang, Yongzhou
- Életkor
- 45 év to 74 év
- People
- 1500
- Run by
- Hunan Cancer Hospital
See details and how to joinNCT07676383 - 2. fázisTaking peopleNeoadjuvant Radiotherapy Combined With NALIRIFOX and Adebrelimab in pMMR/MSS Locally Advanced Rectal Cancer: A Prospective, Randomized, Phase II Clinical Trial
- Where
- Guangzhou
- Életkor
- 18 év to 75 év
- People
- 84
- Run by
- Sun Yat-sen University
See details and how to joinNCT07622771 - No phaseNot yet taking people in KínaEffectiveness of Artificial Intelligence-Assisted Colonoscopy for Adenoma Detection in Routine Clinical Practice : a Prospective Multicenter Randomized Trial
- Where
- Hangzhou
- Életkor
- 40 év to 74 év
- People
- 3300
- Run by
- Zhejiang University
See details and how to joinNCT07307547 - No phaseTaking peopleSafety of Mid and Low Rectal Cancer Surgery Without Dissection of the No.253 Lymph Node (S-M-O-O-T-H)
- Where
- Beijing, Chengdu, Shanghai
- Életkor
- 18 év to 75 év
- People
- 1384
- Run by
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
See details and how to joinNCT06146946 - No phaseTaking peopleClinical Efficacy of Transarterial Infusion Chemotherapy for Unresectable Colorectal Cancer
- Where
- Xicheng
- Életkor
- 18 év and over
- People
- 50
- Run by
- Guang'anmen Hospital of China Academy of Chinese Medical Sciences
See details and how to joinNCT07333053 - No phaseTaking peopleHDR Endorectal Brachytherapy With 3D-Printed Guidance and Local Shielding for Rectal Cancer Organ Preservation
- Where
- Tianjin
- Életkor
- 18 év to 80 év
- People
- 50
- Run by
- Tianjin Medical University Cancer Institute and Hospital
See details and how to joinNCT07786493 - 2. fázisNot yet taking people in KínaRetlirafusp Alfa Plus Targeted Therapy and Chemotherapy for Unresectable Colorectal Liver-Limited Metastases
- Where
- Beijing
- Életkor
- 18 év to 79 év
- People
- 80
- Run by
- Peking University Cancer Hospital & Institute
See details and how to joinNCT07815288 - 3. fázisTaking peopleA Clinical Study of SHR-A1811 in Combination With Chemotherapy and Bevacizumab Versus Standard Therapy as First-Line Treatment for Advanced Colorectal Cancer
- Where
- Beijing
- Életkor
- 18 év to 75 év
- People
- 300
- Run by
- Suzhou Suncadia Biopharmaceuticals Co., Ltd.
See details and how to joinNCT07676162 - 3. fázisTaking peopleEfficacy and Safety of Tunlametinib Plus Vemurafenib in Patients With BRAF V600E-mutant Metastatic Colorectal Cancer
- Where
- Beijing
- Életkor
- 18 év to 70 év
- People
- 165
- Run by
- Shanghai Kechow Pharma, Inc.
See details and how to joinNCT06008119 - 2. fázisTaking peopleIvosidenib Plus mFOLFOXIRI and Celecoxib for BRAF-targeted Therapy-refractory BRAF V600E-mutant Colorectal Cancer Patients
- Where
- Guangzhou
- Életkor
- 18 év to 70 év
- People
- 45
- Run by
- Sun Yat-sen University
See details and how to joinNCT07809893 - 2. fázisNot yet taking people in KínaTotal Neoadjuvant mFOLFOX6 Plus Suvemcitug and Enlonstobart With Selective Omission of Pelvic Radiotherapy for High-Risk Mid-Rectal Locally Advanced Rectal Cancer
- Where
- Shanghai
- Életkor
- 18 év to 75 év
- People
- 52
- Run by
- Fudan University
See details and how to joinNCT07810114 - 1/2. fázisTaking peopleA Study of HDM2017 Combination Therapy in Advanced Colorectal Cancer
- Where
- Beijing
- Életkor
- 18 év to 75 év
- People
- 220
- Run by
- Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
See details and how to joinNCT07805551 - No phaseTaking peopleRemimazolam for Postoperative Sleep in Elderly Patients
- Where
- Yinchuan
- Életkor
- 65 év to 80 év
- People
- 84
- Run by
- General Hospital of Ningxia Medical University
See details and how to joinNCT07740343 - No phaseTaking peoplePostoperative Circulating Tumor DNA Monitoring in Stage I-III Driver-Mutant Colon Adenocarcinoma
- Where
- Shanghai
- Életkor
- 18 év to 75 év
- People
- 392
- Run by
- Ruijin Hospital
See details and how to joinNCT07795528 - 2. fázisNot yet taking people in KínaA Single-Arm, Phase II Study of Retlirafusp Alfa in Combination With XELOX and Bevacizumab for the First-Line Treatment of Advanced RAS-Mutated Colorectal Cancer With Liver Metastases (CRLM)
- Where
- Beijing
- Életkor
- 18 év to 75 év
- People
- 46
- Run by
- Dai, Guanghai
See details and how to joinNCT07797244